Physician profile
Jarrell Rayner
NPI 1902434814
$1,365.47
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $633 · 2024: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $203.24 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $179.20 | 2023-2024 | |
| Amgen INC. | $132.98 | 2023-2024 | Otezla, Repatha, Evenity |
| Novartis Pharmaceuticals Corporation | $103.22 | 2024 | |
| Novo Nordisk INC | $86.87 | 2023-2024 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $81.67 | 2023-2024 | Breztri |
| Janssen Pharmaceuticals, INC | $64.43 | 2023-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.48 | 2023-2024 | Trulance, Xifaxan |
| Glaxosmithkline, LLC. | $60.07 | 2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Edwards Lifesciences Corporation | $52.73 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $42.60 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $41.01 | 2023-2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $39.52 | 2023-2024 | |
| Pfizer INC. | $37.95 | 2023-2024 | |
| Exeltis, USA INC. | $34.61 | 2023 | Slynd |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $32.00 | 2024 | Rexulti |
| Hologic Sales and Service, LLC | $25.78 | 2024 | Thinprep 2000 Processor |
| Lundbeck LLC | $21.17 | 2023 | Rexulti |
| Corium, LLC | $17.44 | 2023 | Azstarys |
| Esperion Therapeutics, INC. | $16.69 | 2023 | Nexletol |
| Antares Pharma, INC. | $15.62 | 2024 | Xyosted |
| Merck Sharp & Dohme LLC | $14.19 | 2023 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrell Rayner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.